Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Cancer Cell International, 05/11/2012
Turk CM et al. – The differential expression of paralemmin in a subset of breast cancers suggests the existence of variation in membrane dynamics that may be exploited to improve diagnosis or provide a therapeutic target.



